Exhibiting at K-754
Dreem aims to provide effective sleep care to individuals as well as healthcare providers for their patients. Its mission is to become the global leader for screening, diagnosing and treating sleep disorders. Since the company’s founding in 2014, it has raised $60 million from investors including Johnson & Johnson and put together a team of 90, split across New York, Paris and Taipei. Scientific rigor and research are the cornerstone of its unique approach, and it has worked with academic institutions and hospitals across the world, including Stanford Sleep Center, and has created a scientific advisory board of leading sleep doctors and neuroscientists.